We are live on ! Find out more
CCIA

Campbell & Co Investment Adviser Portfolio holdings

AUM $1.91B
1-Year Est. Return 17.57%
This Fund
S&P 500
This Quarter Est. Return
+6.43%
1 Year Est. Return
+17.57%
3 Year Est. Return
+30.96%
5 Year Est. Return
+33.24%
10 Year Est. Return
+189.91%
AUM
$1.59B
AUM Growth
+$283M
Cap. Flow
+$228M
Cap. Flow %
14.35%
Top 10 Hldgs %
6.1%
Holding
1,532
New
540
Increased
294
Reduced
266
Closed
432

Top Buys

Rank Stock Value
1
JCI icon
Johnson Controls International
JCI
+$11.9M
2
BMO icon
Bank of Montreal
BMO
+$10.5M
3
HPQ icon
HP
HPQ
+$9.75M
4
AER icon
AerCap
AER
+$9.53M
5
ITW icon
Illinois Tool Works
ITW
+$8.27M

Top Sells

Rank Stock Value
1
LH icon
Labcorp
LH
+$8.73M
2
SYF icon
Synchrony
SYF
+$8.42M
3
CAH icon
Cardinal Health
CAH
+$7.63M
4
BRO icon
Brown & Brown
BRO
+$7.55M
5
UL icon
Unilever
UL
+$7.37M

Sector Composition

Rank Sector Weight
1 Technology 18.67%
2 Financials 17.36%
3 Industrials 17.08%
4 Consumer Discretionary 12.43%
5 Healthcare 11.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEU icon
1351
NewMarket
NEU
$8.65B
-738
Closed -$418K
NFG icon
1352
National Fuel Gas
NFG
$7.72B
-61,108
Closed -$4.84M
NGG icon
1353
National Grid
NGG
$81.5B
-15,386
Closed -$967K
NJR icon
1354
New Jersey Resources
NJR
$5.62B
-68,604
Closed -$3.37M
NMIH icon
1355
NMI Holdings
NMIH
$3.4B
-21,373
Closed -$770K
NOK icon
1356
Nokia
NOK
$59.4B
-133,543
Closed -$704K
NOV icon
1357
NOV
NOV
$7.37B
-50,380
Closed -$767K
NSSC icon
1358
Napco Security Technologies
NSSC
$1.38B
-13,770
Closed -$317K
NTLA icon
1359
Intellia Therapeutics
NTLA
$1.66B
-28,302
Closed -$201K
NTRS icon
1360
Northern Trust
NTRS
$34.8B
-25,808
Closed -$2.55M
NVDA icon
1361
NVIDIA
NVDA
$5.47T
-3,138
Closed -$340K
NVR icon
1362
NVR
NVR
$17B
-305
Closed -$2.21M
NVS icon
1363
Novartis
NVS
$288B
-14,940
Closed -$1.67M
NVST icon
1364
Envista
NVST
$4.5B
-19,592
Closed -$338K
NVT icon
1365
nVent Electric
NVT
$27.7B
-43,200
Closed -$2.26M
NWN icon
1366
Northwest Natural Holdings
NWN
$2.13B
-18,920
Closed -$808K
NYT icon
1367
New York Times
NYT
$10.4B
-11,408
Closed -$566K
OBK icon
1368
Origin Bancorp
OBK
$1.68B
-19,184
Closed -$665K
ODP
1369
DELISTED
ODP
ODP
-11,940
Closed -$171K
OGE icon
1370
OGE Energy
OGE
$9.68B
-152,973
Closed -$7.03M
OGS icon
1371
ONE Gas
OGS
$5.08B
-63,815
Closed -$4.82M
OLLI icon
1372
Ollie's Bargain Outlet
OLLI
$4.7B
-1,732
Closed -$202K
OLP
1373
One Liberty Properties
OLP
$533M
-11,021
Closed -$290K
OMAB icon
1374
Grupo Aeroportuario Centro Norte
OMAB
$5.21B
-10,104
Closed -$794K
OPBK icon
1375
OP Bancorp
OPBK
$235M
-10,061
Closed -$121K

Similar funds

Campbell & Co Investment Adviser's Q2 2025 Portfolio in Review

As of Q2 2025, Campbell & Co Investment Adviser held 1,532 positions worth $1.59B, up 22% from $1.3B the previous quarter. Its ten largest holdings account for 6.1% of the portfolio.

Campbell & Co Investment Adviser deployed $228M of net new capital in Q2 2025, opening 540 new positions and adding to 294 existing holdings. Its largest new stake was Johnson Controls International: 128,951 shares worth $13.6M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 9.9% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Cardinal Health, an estimated $7.63M trimmed.

  • Campbell & Co Investment Adviser's largest Q2 2025 buy was Johnson Controls International: 128,951 shares worth $13.6M.
  • Campbell & Co Investment Adviser added most to Dover in Q2 2025, an estimated $7.63M increase.
  • Campbell & Co Investment Adviser's biggest Q2 2025 reduction was Cardinal Health, cutting an estimated $7.63M.
  • Campbell & Co Investment Adviser fully exited Labcorp in Q2 2025, selling an estimated $8.73M.
  • Campbell & Co Investment Adviser's ten largest holdings make up 6.1% of its $1.59B portfolio in Q2 2025.
  • Campbell & Co Investment Adviser opened 540 new positions and closed 432 in Q2 2025.
  • Campbell & Co Investment Adviser's portfolio value rose 22% quarter-over-quarter to $1.59B.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2025, filed 7 Aug 2025.